<DOC>
	<DOCNO>NCT00002367</DOCNO>
	<brief_summary>To evaluate efficacy Saquinavir-SGC combination Zidovudine Lamivudine treatment HIV-1 infect patient previous anti-retroviral drug therapy .</brief_summary>
	<brief_title>A Study Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine Treatment HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs</brief_title>
	<detailed_description>All enrol patient receive follow 3 drug combination : Saquinavir , Zidovudine Lamivudine . Efficacy duration anti-viral response evaluate monitor HIV-1 RNA level . Patients detectable limit 200 copies/ml analyze use Ultra-direct method detection limit 20 copies/ml . CD4 CD8 cell count also analyze .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : Plasma HIV1 RNA titer &gt; 10,000 copies/ml . CD4 cell count &gt; 100 cells/mm3 . Exclusion Criteria Coexisting Condition : Patients follow condition exclude : Any prior antiretroviral drug therapy . Prior Medication : Excluded : Previous antiretroviral drug therapy .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1997</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>Saquinavir</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>